Phlorizin

Overview

Phlorizin (Floridzin) is an orally active non-selective sodium-glucose cotransporter ( SGLT ) inhibitor, with an IC 50 of 0.04 μM and a K i of 39 nM against hSGLT2 , and an IC 50 of 0.17 μM and a K i of 0.31 μM against hSGLT1 . Phlorizin promotes GLUT4 translocation, inhibits gluconeogenesis and promotes glycogen synthesis by activating the PI3K/Akt/mTOR pathway. Phlorizin reduces DNA damage and apoptosis ( apoptosis ) by inhibiting the NF-κB inflammatory pathway. Phlorizin induces apoptosis via activating the Caspase pathway by antagonizing the JAK/STAT3 and PCK pathways. Phlorizin also exhibits antibacterial , anti-inflammatory and neuroprotective activities.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > Caspase | Products > Signaling Pathways > STAT | Products > Signaling Pathways > SGLT | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > GLUT | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Akt | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > JAK | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > mTOR

Product Information

• Catalog No.: HY-N0143
• CAS No.: 60-81-1
• Molecular Formula: C21H24O10
• Molecular Weight: 436.41
• Purity: 99.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.73 mM); Clear solution
• Availability: In-stock

Source

Original product source